Literature DB >> 12370716

Congenital malformation of the gastrointestinal tract in Aseer region, Saudi Arabia.

Asindi A Asindi1, Saad A Al-Daama, Mohammed S Zayed, Yousef A Fatinni.   

Abstract

OBJECTIVE: The aim of this prospective study was to evaluate the prevalence and pattern of congenital malformations of the gastrointestinal tract among the Saudi newborn population in Aseer region, Kingdom of Saudi Arabia.
METHODS: Every consecutive newborn admitted to the neonatal intensive care unit of Aseer Central Hospital, Kingdom of Saudi Arabia with features of gastrointestinal tract anomaly during the period January 1995 to December 2000 had relevant data obtained and entered into a program form.
RESULTS: During the 6 year period, a total of 1386 Saudi infants were admitted into the neonatal intensive care unit of Aseer Central Hospital. Of these, 12.4% were confirmed to have congenital malformation of the gastrointestinal tract; male/female ratio of 1.7:1. The total number of live births by Saudi mothers in Aseer region during the period was 128,093, giving an incidence rate of 1.3 per 1000 live births. The 172 newborns presented with 174 anomalies of the gastrointestinal tract. The leading malformations were imperforate anus (78 cases or 44.8%), tracheosophageal fistula/atresia (42 cases or 24.1%) and intestinal atresia (37 cases or 21.3%). Other lesions included Hirschsprung's disease (14 cases or 8%) and stenosis (2 pyloric and one duodenal) (1.7%). Some patients had more than one defect within the tract (1%) and multisystemic defects (23%). The overall fatality rate was (12%), due largely to post-operative infection (75% of cases) and multiple anomalies (25% of cases).
CONCLUSION: The prevalence of congenital defect of the gastrointestinal tract in Aseer region appears to be high. The incidence of associated multisystemic anomalies is also high. Fatality incidence is influenced by post-operative sepsis and associated multiple defects. A high incidence of consanguineous marriage in the region may be the underlying etiological factor hence genetic counseling may be helpful.

Entities:  

Mesh:

Year:  2002        PMID: 12370716

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  7 in total

1.  Congenital cardiac anomalies and imperforate anus: A hospital's experience.

Authors:  Jamal S Kamal; Ahmad S Azhar
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

2.  Gastrointestinal malformations in Gorgan, North of Iran: epidemiology and associated malformations.

Authors:  Mohammad Jafar Golalipour; Elham Mobasheri; Kaniz-Reza Hoseinpour; Abbas Ali Keshtkar
Journal:  Pediatr Surg Int       Date:  2006-10-17       Impact factor: 1.827

Review 3.  Humans, mice, and mechanisms of intestinal atresias: a window into understanding early intestinal development.

Authors:  Peter F Nichol; Amy Reeder; Robert Botham
Journal:  J Gastrointest Surg       Date:  2010-11-30       Impact factor: 3.452

4.  Risk factors and birth prevalence of birth defects and inborn errors of metabolism in Al Ahsa, Saudi Arabia.

Authors:  Waleed Hamad Al Bu Ali; Magdy Hassan Balaha; Mohammed Saleh Al Moghannum; Ibrahim Hashim
Journal:  Pan Afr Med J       Date:  2011-02-23

Review 5.  Individualized medicine enabled by genomics in Saudi Arabia.

Authors:  Muhammad Abu-Elmagd; Mourad Assidi; Hans-Juergen Schulten; Ashraf Dallol; Peter Pushparaj; Farid Ahmed; Stephen W Scherer; Mohammed Al-Qahtani
Journal:  BMC Med Genomics       Date:  2015-01-15       Impact factor: 3.063

6.  Esophageal atresia with or without tracheoesophageal fistula: success and failure in 94 cases.

Authors:  Ahmed H Al-Salem; Maaen Tayeb; Suzi Khogair; Anita Roy; Nuhad Al-Jishi; Kefah Alsenan; Hussain Shaban; Muzaffar Ahmad
Journal:  Ann Saudi Med       Date:  2006 Mar-Apr       Impact factor: 1.526

7.  Antenatal diagnosis, prevalence and outcome of major congenital anomalies in Saudi Arabia: a hospital-based study.

Authors:  Bahauddin I Sallout; Manal S Al-Hoshan; Reham A Attyyaa; Abdelmane A Al Suleimat
Journal:  Ann Saudi Med       Date:  2008 Jul-Aug       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.